Biohaven Pharmaceutical Holding Co Ltd.

D. E. Shaw & Co., Inc.

Report date

9/30/2022

Quarter

2022 Q3

Filed

11/14/2022

Shares

101,674

Value ($000)

15,370

Weight

0.0%

2019 Q4 - 2022 Q3 (12 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2022 Q3	11/14/2022	15,370	0.0%	101,674	9/30/2022
2022 Q2	8/15/2022	33,331	0.1%	228,747	6/30/2022
2022 Q1	5/16/2022	905	0.0%	7,631	3/31/2022
2021 Q4	2/14/2022	7,029	0.0%	51,007	12/31/2021
2021 Q3	11/15/2021	16,768	0.0%	120,710	9/30/2021
2021 Q2	8/16/2021	4,665	0.0%	48,054	6/30/2021
2021 Q1	5/17/2021	9,455	0.0%	138,335	3/31/2021
2020 Q4	2/16/2021	14,015	0.0%	163,509	12/31/2020
2020 Q3	11/16/2020	11,695	0.0%	179,897	9/30/2020
2020 Q2	8/14/2020	9,061	0.0%	123,940	6/30/2020
2020 Q1	5/15/2020	4,727	0.0%	138,897	3/31/2020
2019 Q4	2/14/2020	7,418	0.0%	136,265	12/31/2019